Publication:
Drugs for the prevention and treatment of pruritus in patients receiving neuraxial opioids

Simple item page
dc.contributor.authorSirilak Suksompongen_US
dc.contributor.authorShusee Visalyaputraen_US
dc.contributor.authorSuwannee Suraseranivongseen_US
dc.contributor.authorPorjai Pattanittumen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherKhon Kaen Universityen_US
dc.date.accessioned2018-12-11T03:30:22Z
dc.date.accessioned2019-03-14T08:02:09Z
dc.date.available2018-12-11T03:30:22Z
dc.date.available2019-03-14T08:02:09Z
dc.date.issued2016-08-30en_US
dc.description.abstract© 2016 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of this review is to evaluate the efficacy and safety of drugs for preventing or treating pruritus in patients receiving neuraxial opioids. We will evaluate whether drugs given prior to or after onset of pruritus alter the risks of pruritus and other side-effects (somnolence, increased analgesic requirement) in patients receiving spinal or epidural opioids.en_US
dc.identifier.citationCochrane Database of Systematic Reviews. Vol.2016, No.8 (2016)en_US
dc.identifier.doi10.1002/14651858.CD007251.pub2en_US
dc.identifier.issn1469493Xen_US
dc.identifier.other2-s2.0-84984630322en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/41215
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84984630322&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleDrugs for the prevention and treatment of pruritus in patients receiving neuraxial opioidsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84984630322&origin=inwarden_US

Files

Collections

Scopus 2016-2017